本页面由Tiger Trade Technology Pte. Ltd.提供服务

Puma Biotechnology Inc

9.12
-0.1200-1.30%
盘后9.380.2608+2.86%19:30 EDT
成交量:26.61万
成交额:242.37万
市值:4.71亿
市盈率:18.11
高:9.30
开:9.30
低:8.99
收:9.24
52周最高:9.51
52周最低:4.30
股本:5,162.01万
流通股本:3,962.45万
量比:0.93
换手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):0.5036
每股收益(LYR):0.6100
净资产收益率:21.97%
总资产收益率:9.81%
市净率:3.40
市盈率(LYR):14.95

数据加载中...

2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

重要事件披露

Form 8-K - Current report
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities